Scientific article

Traitement actuel de la maladie de Parkinson : difficultés et controverses

Published inRevue médicale suisse, vol. 1, no. 18, p. 1214,1216-1219
Publication date2005

Treating patients with Parkinson's disease is not an easy task for the physician who is facing a disease well responsive to symptomatic therapy, yet escaping any curative approaches. In spite of the large therapeutic armamentarium available, many issues remained unsolved, as indications of a particular therapeutic agent are only loosely defined and evolving according to various parameters such as disease progression and severity, the profile of potentially serious adverse effects, the physician's level of expertise and patient's expectations. The growing experience acquired with subthalamic nucleus deep brain stimulation has shown that indications for such a surgery have to be cautiously examined. After initial therapeutic enthusiasm, we are now at a time of problems and controversies.

  • Antiparkinson Agents/therapeutic use
  • Catechol O-Methyltransferase Inhibitors
  • Dopamine Agonists/therapeutic use
  • Humans
  • Levodopa/therapeutic use
  • Muscarinic Antagonists/therapeutic use
  • Parkinson Disease/therapy
Citation (ISO format)
BURKHARD, Pierre, VILLEMURE, Jean-Guy, VINGERHOETS, François. Traitement actuel de la maladie de Parkinson : difficultés et controverses. In: Revue médicale suisse, 2005, vol. 1, n° 18, p. 1214,1216–1219.
ISSN of the journal1660-9379

Technical informations

Creation01/15/2015 11:52:00 AM
First validation01/15/2015 11:52:00 AM
Update time03/14/2023 10:42:12 PM
Status update03/14/2023 10:42:12 PM
Last indexation05/02/2024 3:56:27 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack